Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α
Top Cited Papers
Open Access
- 1 July 2002
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (7) , 2005-2011
Abstract
The possibility that lipid-induced insulin resistance in human muscle is related to alterations in diacylglycerol (DAG)/protein kinase C (PKC) signaling was investigated in normal volunteers during euglycemic-hyperinsulinemic clamping in which plasma free fatty acid (FFA) levels were increased by a lipid/heparin infusion. In keeping with previous reports, rates of insulin-stimulated glucose disappearance (GRd) were normal after 2 h but were reduced by 43% (from 52.7 ± 8.2 to 30.0 ± 5.3 μmol · kg–1 · min–1, P < 0.05) after 6 h of lipid infusion. No changes in PKC activity or DAG mass were seen in muscle biopsy samples after 2 h of lipid infusion; however, at ∼6 h, PKC activity and DAG mass were increased approximately fourfold, as were the abundance of membrane-associated PKC-βII and -δ. A threefold increase in membrane-associated PKC-βII was also observed at ∼2 h but was not statistically significant (P = 0.058). Ceramide mass was not changed at either time point. To evaluate whether the fatty acid–induced insulin activation of PKC was associated with a change in the IkB kinase (IKK)/nuclear factor (NF)-κB pathway, we determined the abundance in muscle of IκB-α, an inhibitor of NF-κB that is degraded after its phosphorylation by IKK. In parallel with the changes in DAG/PKC, no change in IκB-α mass was observed after 2 h of lipid infusion, but at ∼6 h, IκB-α was diminished by 70%. In summary, the results indicated that the insulin resistance observed in human muscle when plasma FFA levels were elevated during euglycemic-hyperinsulinemic clamping was associated with increases in DAG mass and membrane-associated PKC-βII and -δ and a decrease in IκB-α. Whether acute FFA-induced insulin resistance in human skeletal muscle is caused by the activation of these specific PKC isoforms and the IKK-β/IκB/NFκB pathway remains to be established.Keywords
This publication has 45 references indexed in Scilit:
- Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of IkkβScience, 2001
- Prevention of fat-induced insulin resistance by salicylateJournal of Clinical Investigation, 2001
- Protein Kinase C-ζ Phosphorylates Insulin Receptor Substrate-1 and Impairs Its Ability to Activate Phosphatidylinositol 3-Kinase in Response to InsulinJournal of Biological Chemistry, 2001
- Differential Effects of Sphingomyelin Hydrolysis and Resynthesis on the Activation of NF-κB in Normal and SV40-transformed Human FibroblastsJournal of Biological Chemistry, 2000
- Activation of Nuclear Factor-κB in Cultured Endothelial Cells by Increased Glucose Concentration: Prevention by Calphostin CJournal of Cardiovascular Pharmacology, 1997
- Mechanism of free fatty acid-induced insulin resistance in humans.Journal of Clinical Investigation, 1996
- Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.Journal of Clinical Investigation, 1995
- Mechanisms of fatty acid-induced inhibition of glucose uptake.Journal of Clinical Investigation, 1994
- Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"Nature, 1990
- Diacylglycerol activation of protein kinase C is modulated by long-chain acyl-CoABiochemical and Biophysical Research Communications, 1988